Did finally the penny drop?
65% improvement is huge. Imagine what just 30% would mean to a stage 4 patient. So far there are many monoclonal PD1 inhibitors trialed and a few on the market selling for multi billion USD. But almost all come with serious side effects, don't last unless constantly re-administered and have no observed / reported triggered immune system memory effect. From my research only IVX 043 pre-clinical and IMU's CF33 / Her-Vaxx and PD1-Vaxx in clinical trials have ever achieved that.
GLTA
Ann: INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY, page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $9.749K | 3.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 5921287 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 9207831 | 14 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |